These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9699049)

  • 21. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: a comparative study of histopathology and frequency of hepatitis B markers.
    Okuda K; Nakashima T; Sakamoto K; Ikari T; Hidaka H; Kubo Y; Sakuma K; Motoike Y; Okuda H; Obata H
    Cancer; 1982 Feb; 49(3):450-5. PubMed ID: 6277447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver.
    Le Moigne F; Durieux M; Bancel B; Boublay N; Boussel L; Ducerf C; Berthezène Y; Rode A
    Magn Reson Imaging; 2012 Jun; 30(5):656-65. PubMed ID: 22459435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MnDPDP enhancement characteristics and differentiation between cirrhotic and noncirrhotic livers.
    Martí-Bonmatí L; Lonjedo E; Poyatos C; Casillas C
    Invest Radiol; 1998 Oct; 33(10):717-22. PubMed ID: 9788132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity.
    Tanabe M; Ito K; Shimizu A; Fujita T; Onoda H; Yamatogi S; Washida Y; Matsunaga N
    Magn Reson Imaging; 2009 Jul; 27(6):801-6. PubMed ID: 19144487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MR features of small hepatocellular carcinoma in normal, fibrotic, and cirrhotic livers: a comparative study.
    Sheng RF; Zeng MS; Ji Y; Yang L; Chen CZ; Rao SX
    Abdom Imaging; 2015 Oct; 40(8):3062-9. PubMed ID: 26329976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance of focal liver lesions in hepatic cirrhosis and chronic hepatitis.
    Martín J; Puig J; Darnell A; Donoso L
    Semin Ultrasound CT MR; 2002 Feb; 23(1):62-78. PubMed ID: 11866223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
    Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI.
    Shah TU; Semelka RC; Pamuklar E; Firat Z; Gerber RD; Shrestha R; Russo MW
    Am J Gastroenterol; 2006 Mar; 101(3):533-40. PubMed ID: 16542290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatocellular carcinoma without cirrhosis in Japanese patients.
    Okuda K; Nakashima T; Kojiro M; Kondo Y; Wada K
    Gastroenterology; 1989 Jul; 97(1):140-6. PubMed ID: 2542116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of clinical manifestations and outcomes of noncirrhotic and cirrhotic hepatocellular carcinoma patients with chronic hepatitis B.
    Hwan YJ; Shin J; Jin YJ; Lee JW
    Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):66-73. PubMed ID: 31268949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
    Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
    Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT.
    Kanematsu M; Hoshi H; Murakami T; Inaba Y; Kim T; Yamada T; Kato M; Yokoyama R; Nakamura H
    AJR Am J Roentgenol; 1997 Dec; 169(6):1507-15. PubMed ID: 9393154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detectability of hepatocellular carcinoma by gadoxetate disodium-enhanced hepatic MRI: tumor-by-tumor analysis in explant livers.
    Nakamura Y; Tashiro H; Nambu J; Ohdan H; Kakizawa H; Date S; Awai K
    J Magn Reson Imaging; 2013 Mar; 37(3):684-91. PubMed ID: 23055436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver cell dysplasia: association with hepatocellular carcinoma, cirrhosis and hepatitis B antigen carrier status.
    Cohen C; Berson SD; Geddes EW
    Cancer; 1979 Nov; 44(5):1671-6. PubMed ID: 227574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fat-suppressed T2-weighted MR imaging of hepatocellular carcinoma and metastases: comparison of conventional spin-echo, fast spin-echo, and echoplanar pulse sequences.
    Kanematsu M; Hoshi H; Murakami T; Itoh K; Hori M; Inaba Y; Kondo H; Yokoyama R; Nakamura H
    J Magn Reson Imaging; 1999 Jul; 10(1):25-32. PubMed ID: 10398974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging.
    Ito K; Mitchell DG; Gabata T; Hann HW; Kim PN; Fujita T; Awaya H; Honjo K; Matsunaga N
    Radiology; 1999 Jul; 212(1):235-40. PubMed ID: 10405747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.